Lecap Asset Management LTD Exelixis, Inc. Transaction History
Lecap Asset Management LTD
- $428 Billion
- Q1 2025
A detailed history of Lecap Asset Management LTD transactions in Exelixis, Inc. stock. As of the latest transaction made, Lecap Asset Management LTD holds 19,051 shares of EXEL stock, worth $812,906. This represents 0.16% of its overall portfolio holdings.
Number of Shares
19,051
Previous 10,454
82.24%
Holding current value
$812,906
Previous $348 Million
102.05%
% of portfolio
0.16%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding EXEL
# of Institutions
613Shares Held
257MCall Options Held
1.57MPut Options Held
730K-
Black Rock Inc. New York, NY33.5MShares$1.43 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.22 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$962 Million4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$633 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$503 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $13.7B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...